Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zen Technologies Ltd. Interim / Quarterly Report 2020

Aug 8, 2020

60795_rns_2020-08-08_fa82a174-6b82-49bb-bec4-4c3e56c2de0d.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

ZEN TECHNOLOGIES LIMITED

... ..... . ·- - 1,;ertllled ISO 9001:2015, ISO 27001:2013, ISO 14001:2015, CMMI ML5 Regd. Office : B-42, Industrial Estate, Sanathnagar Hyderabad - 500 018, Telangana, India Phone: +91 40 23813281, Fax No: +91 40 23813694 Email: [email protected] Website: www.zen.in Corporate Identity Number: L72200TG1993PLC015939

Date. . 08 August 2

To BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001 Through: BSE Listing Centre Security Code: 533339

To

National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai- 400 051 Through: NEAPS Symbol/Security ID: ZENTEC

Dear Sir/Madam,

Sub: 1. Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended 30 June 2020.

  1. Outcome of the Board Meeting held on 08 August 2020.

This is to inform you that the Board of Directors of the Company at its meeting held today i.e., on Saturday, 08 August 2020, inter-alia, considered and approved the following:-

    1. Unaudited financial results, both standalone and consolidated, for the quarter ended 30 June 2020. The said financial results along with the Limited Review Report and Statement of Deviation or Variation, is enclosed as Annexure- I.
    1. Approved the following changes in the Directors I Key Managerial Personnel of the company:
  • a. Appointment of Ms. Sirisha Chintapalli (DIN: 08407008) as the Additional Director in the category of Non-Executive and Independent of the company w.e.f. August 8, 2020. The other details are enclosed as Annexure-11.
  • b. Re-appointment of Mr. Ashok Atluri (DIN: 00056050) as the Managing Director of the company for a period of three (3) years from O 1 October 2020 till 30 September 2023 subject to the approval of shareholders at the ensuing Annual General Meeting. The other details are enclosed as Annexure-11.
  • c. Re-appointment of Mr. Kishore Dutt Atluri, to hold and continue to hold office as President of the Company for a further period of five years with effect from 01 October 2020 till 30 September 2025 subject to the approval of shareholders at the ensuing Annual General Meeting.

Mr. Kishore Dutt Atluri is the brother of Mr. Ashok Atluri, Chairman and Managing Director of the Company.

  1. Approved acquisition of 100% shareholding of Zen Medical Technologies Private Limited (ZMTPL) by way of investment in equity through acquiring existing promoter shares. On completion of acquisition of 100% shareholding, ZMTPL will be a wholly-owned subsidiary of the Company.

Further the details as required under the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09 September 2015 relating to the proposed acquisition is enclosed as Annexure- III.

  1. Approved the alterations to the Memorandum of Association (MOA) of the Company in order to make it in line with the requirements of the provisions of Companies Act, 2013 which is subject to the approval of shareholders at the ensuing Annual General Meeting.

The above information is also available on the website of the Company: www.zentechnologies.com.

The meeting of Board of Directors was commenced at 12.00 Noon and concluded at 3.45 p.m.

This is for your kind information and records.

Thanking You.

Yours sincerely,

For :; k,nRologiest Limited

H a:s~/;Jng 1 aJpu Company Secretary & Compliance Officer M. No. A38213

M/s ZEN TECHNOLOGIES LIMITED
CIN:L72200TG1993PLC015939
B-42 Industrial Estate, Sanathnagar Hyderabad - 500 018, Telangana, India
Un Audited Standalone financial results for the Quarter ended 30th June 2020
S.No Particulars Quarter ended
30.06.2020
Quarter ended
31.03.2020
Quarter ended
30.06.2019
(Rs. In lakhs)
Year ended
31.03.2020
Un-Audited Audited Un-Audited Audited
1 Income 14,698.00
Revenue From Operations 416.24 1.871.01 4,878.72 190.61
Other Income 69 22 94.42 27.50
Total Income 485.46 1,965.43 4,906.22 14,888.61
$2$ Expenses
Cost of Materials and Components consumed 13.60 171.92 1,345.25 2,509.13
Changes in inventories of finished goods,
work-in-progress and Stock-in-Trade (13.60) 216.55 150.67
169.01
1,385.73
580.41
Manufacturing Expenses 48.17 164.46 355.44 1,667.97
Employee Benefits Expense 273.14 494.68 100.55 318.23
Finance Costs 10.79 93.78
95.82
93.13 375.25
Depreciation and Amortization Expense 101.14
184.45
640.23 420.44 2,195.63
Other Expenses 617.69 1,877.44 2,634.49 9,032.35
Total Expenses
3 Profit/(Loss) before exceptional and extraordinary items (1 - 2) (132.23) 87.99 2,271.73 5,856.26
4 Exceptional Items 87.99 2,271.73 5,856.26
5 Profit /(Loss) before extra-ordinary items and tax (3-4) (132.23)
6 Extraordinary items 87.99 2,271.73 5,856.26
$7$ Profit / (Loss) before Tax (5-6) (132.23)
8 Tax expense
$(i)$ Current tax
13.37 489.53 1,021.20
(ii) Deferred tax (63.65) (1,706,12) 97.16 (1, 215.63)
Total Tax (63.65) (1,692.75) 586.69 (194.43)
9 Net Profit/(Loss) from continuing operations (7-8) (68.58) 1,780.74 1,685.04 6,050.69
10 Profit / (Loss) from discontinuing operations
11 Tax expense of discontinuing operations
12 Net Profit /(Loss) from discontinuing operations (10 - 11)
13 Net Profit /(Loss) for the period (9+12) (68.58) 1,780.74 1,685.04 6,050.69
14 Other Comprehensive Income
Items that will not be reclassified subsequently to statement of profit or loss 2.70 2.70
Income tax relating to items that will not be reclassified to profit / loss (0.79) (0.79)
Total Other Comprehensive Income 1.91 1.91
15 Paid-up Equity Share Capital
(Rs.1/- per Equity Share)
771.60 771.60 771.60 771.60
16 Other Equity 19,874.60
1,685.04 6,052.60
17 Total Comprehensive Income for the year (13+14) (68.58) 1,782.65
Earning per Equity Share of Face Value of Rs. 1/- Each (0.09) 2.31 2.18 7.84
Basic (In Rs.) -
Diluted (In Rs.)-
(0.09) 2.31 2.18 7.84

u •• - Notes to Standalone11Audited Financial Results for the Quarter ended 30th June 2020.

1 The Financial results of the company have been prepared in accordance with Indian Accounting Standards (Ind AS) notified by the Companies (Indian Accounting Standard) rules 2015 as amended.
2 The aforementioned results have been reviewed & recommended by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on 08th Aug, 2020.
3 The figures for previous periods/ Year have been Recasted and Regrouped, wherever necessary.
4 The entire operations of the Company relate to only one segment viz., Training & Simulation. Hence segmental reporting as per Ind AS 108 is not made.
5 Till the Period ended 30th June 2020. the company has invested in Zen Technologies USA. Inc. (a wholly owned Subsidiary) an amount of Rs. 1434.67 lakhs.
6 The value of the orders on hand as at 08th Aug, 2020 is about Rs. l 73.42 Crores.

Place : Hyderabad Date : 08th Aug, 2020.

Independent Auditor's Review Report on Unaudited Quarterly Standalone Financial Results of Zen Technologies Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended)

To

The Board of Directors. M/s Zen Technologies Limited

We have reviewed the accompanying statement of unaudited Standalone financial results of M/S. Zen Technologies Limited ('the company') for the quarter ended 30th June, 2020 ('the statement'), being submitted by the company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBI from time to time.

This statement, which is the responsibility of the Company's Management and approved by the Board of Directors/Committee of Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 Interim financial reporting (Ind AS 34). Prescribed under section 133 of the Companies Act 2013, read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review.

We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.

Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying statement, prepared in accordance with the aforesaid Indian accounting standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended) including the manner in which it is to be disclosed, or that it contains any material misstatement.

We have reviewed the financial results and other information presented in accordance with IND AS for the quarter ended $30th$ June, 2020 and have been presented solely on the basis of information compiled by the management.

For Ramasamy Koteswara Rao and Co LLP

FRN.No.010396S /S200084 (Murali Krishna Reddy Telluri)

Chartered Accountants

Partner Membership No: 223022 UDIN: 20223022AAAAJF4606

SRI RAMCHANDRA ARCADE, D.No.8-2-293/82/JIII/573/M/ 1st Floor, Road No.82, Jubilee Hills, Hyderabad - 500096. Ph: 23394982/85, E-mail: [email protected], Website : www.rkandco.in

Place: Hyderabad Date: 08-08-2020

' ' ~1/s ZEN TECHNOLOGIES
Ll~llTED
Un Audited Consolidated financial results for the Quarter ended JOrh .lune 2020
S.No Particulars Quarter ended
30.06.2020
Quarter ended
31.03.2020
Quarter ended
30.06.2019
(Rs. In lakhs)
Year ended
31.03.2020
Un-Audited Audited Un-Audited
I Income Audited
Revenue From Operations 416.24 1,978.84 4,892.22 14,928.58
Other Income 69.27 96.45 27.50 192.68
Total Income 485.51 2,075.29 4,919.72 15,121.26
2 Expenses
Cost of Materials and Components consumed 107 67 142 69 1,368 32 2.637.00
Changes in inventories of finished goods,
work-in-progress and Stock-in-Trade ( 107 23) 56.11 139.88 I, 103.19
Manufacturing Expenses 48.17 162.97 169.01 581.70
Employee Benefits Expense
Finance Costs
33430 562.72 424.02 1,963.72
Depreciation and Amortization Expense 12.77
124.32
98.58 I 04.49 334.98
Other Expenses 203.04 118.86
679 00
96.51
477 26
456. 78
2,370.42
Total Expenses 723.0~ 1,820.9~ 2,779.50 9,447.80
3 Profit/(Loss) before exceptional and extraordinary items (I - 2)
4 Share or Profit/(loss) from an Associate
(237.53) 25~.36 2, I ~0.22 5,673A7
5 Profit /(Loss) before extru-ordinary items and tax (3-4) (237.53) 7.23
261.58
(8 51) ( I 28)
6 Extraordinary items 2,131.71 5,672.18
7 Profit I (Loss) before Tax (5-6) (237.53) 261.58 2,131.71 5,672.18
8 Tax expense
(i) Curren! tax
(ii) Deferred tax
16.74 489.53 1,024.57
Total Tax (63.87)
(63.87)
( 1,666 80) 85.71 (1,215.78)
9 Net Profit/(Loss) from continuing operations (7- 8) (173.66) (1,650.06)
1,911.64
575.25
1,556.47
(191.21)
5,863.39
Attriburable to:
Shareholders of the Company ( 133.64) 1,847.9~ 1,572.33 5,876.87
Non Controlling interest
10 Profit I (Loss) from discontinuing operations
(40.02) 63.71 (15.86) ( 13.48)
11 Tax expense of discontinuing operations
12 Net Profit /(Loss) from discontinuing operations (10- 11)
13 Net Profit /(Loss) for the period (9+ 12) (173.66) 1,911.64 1,556.47 5,863.39
14 Other Comprehensive Income
Items that will not be reclassified subsequently to statement of profit or loss - 11.93 9.64
Income tax relating to items that will not be reclassified to profit I loss
Total Other Comprehensive Income
(0 79) (0 79)
- 11.14 8.85
15 Total Comprehensive Income for the year (13+14) (173.66) 1,922.78 1,S56A7 5,872.24
Attributable 10:
Shareholders of the Company
Non Controlling interest
(133.64) 1,859.08 1,572.33 5,885.72
(40.02) 6J.7t ( t 5.86) (13A8)
16 Paid-up Equity Sim re Capital
(Rs 1/- per Equity Share)
771.60 771.60 771.60 771.60
17 Other Equity
Shareholders of the Company 18,3~5.88
Non Controlling interest 659.13
Earning per Equity Share of Face Value of Rs. I/- Each
Basic (In Rs) - (0 17) 2.J9 2 o~ 7 62
Diluted (In Rs.)- (017) 2.39 2 04 7.62

vn-Notes to Consolidated Audited Financial Results for the Quarter ended 30th June 2020. /I .

I The Financial results of the company have been prepared in accordance with Indian Accounting Standards (Ind AS) notified by the Companies (Indian Accounting Standard) rules 2015
as amended.
2 The aforementioned results have been reviewed & recommended by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on 08th Aug, 2020.
3 The figures for previous periods/ Year have been Recasted and Regrouped, wherever necessary.
4 The entire operations of the Company relate to only one segment viz., Training & Simulation. Hence segmental reporting as per Ind AS 108 is not made.
5 Till the Period ended 30th June 2020, the company has invested in Zen Technologies USA, Inc. (a wholly owned Subsidiary) an amount of Rs. 1434.67 lakhs.
6 The value of the orders on hand as at 08th Aug, 2020 is about Rs. 173 .42 Crores.

For and on behalf ofzhe Board

Place: Hyderabad Date : 08th Aug, 2020.

I

Independent Auditor's Review Report on Unaudited Quarterly Consolidated Financial Results of Zen Technologies Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended)

To

The Board of Directors. M/s Zen Technologies Limited

We have reviewed the accompanying statement of unaudited Consolidated financial results of M/s Zen Technologies Limited ('the Holding company') and its Subsidiaries (the Holding Company and its subsidiaries together referred to as "the Group") for the quarter ended 30th June, 2020 ('the statement'), being submitted by the holding company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended), including relevant circulars issued by the SEBI from time to time. This statement is the responsibility of the Holding Company's Management and approved by the Board of Directors/Committee of Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 Interim financial reporting (Ind AS 34), Prescribed under section 133 of the Companies Act 2013, read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement hased on our review.

We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410. Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. The review is limited primarily to inquiries of Holding company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.

accordance We performed procedures in. with the SEBI circular also CIR/CFD/CMD1/44/2019 dated 29 March 2019 issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), to the extent applicable.

The statement includes the results of the following entities:

    1. Zen Technologies USA Inc. USA (Wholly Owned Subsidiary)
    1. Unistring Tech Solutions Private Limited., India, (Subsidiary)

SRI RAMCHANDRA ARCADE, D.No.8-2-293/82/JIII/573/M/ 1st Floor, Road No.82, Jubilee Hills, Hyderabad - 500096. Ph: 23394982/85, E-mail: [email protected], Website : www.rkandco.in

Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying statement, Prepared in accordance with the aforesaid Indian accounting standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including the manner in which it is to be disclosed, or that it contains any material misstatement.

We did not review the interim financial results of the subsidiaries included in the consolidated financial results, whose financial statements reflects total revenues of Rs. Nil for the period ended 30th June, 2020 and total net loss of Rs 87.68 lakhs and the other comprehensive income of Rs. Nil for the quarter ended on 30 June 2020, as considered in the consolidated financial results. These financial statements results have been furnished to us by the management and our opinion on the consolidated financial results, in so far it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the reports of the other auditors.

Our opinion on the statement is not modified in respect of the above matter with respect to our reliance on the work done and the reports of the other auditors.

Chartered

For Ramasamy Koteswara Rao and Co LLP Chartered Accountants FRN.No.010396S/S200084 $ewara$

Place: Hyderabad Date: 08-08-2020

(Murali Krishna Reddy Telluri) Partner Membership No: 223022 UDIN: 20223022AAAAJG1145

Statement of Deviation I Variation in utilisation of funds raised
Name of listed entitv Zen Technologies Limited
Mode of Fund Raising Preferential Issue of
convertible warrants
Date of Raising Funds 04/02/2019 - Date of
allotment of warrants
Amount Raised *Rs. 17,85,95,440/-
Report filed for Quarter ended June 30, 2020
Monitoring Agency Not Applicable
Monitoring Agency Name, if annlicable NA
ls there a Deviation I Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a NA
contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval NA
Explanation for the Deviation I Variation NA
Comments of the Audit Committee after review Nil
Comments of the auditors, if anv Nil
Objects for which funds have been raised and where there has been a deviation, in the followina table
Original Object Modified Object, if any Original
Allocation
Modified
if any
allocation, Funds Utilised Amount of
DeviationNariation for Remarks if
the quarter according to any
applicable object
The proceeds of the preferential issue will be utilized
towards research and development (R&D),
potential acquisitions, export promotion, working capital, NA Rs. 4,46,48,860/- NA Rs. 4,46,48,860/- Nil NA
capital expenditure and general corporate
purposes.
"Out of the total amount raised, only 25% of the amount i.e., Rs. 4,46,48,860/- has been received by the company towards warrant subscription at the time of allotment of warrants. The
warrants are convertible into I equity share each on payment of the exercise money i.e., balance 75% of the amount within a period of 18 months from the date of allotment of the
warrants.
Deviation or variation could mean:
(a) Deviation in the objects or nurnoses for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
( c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc

Chairnian and Managing Director DIN: 00056050

Date - 08 August 2020 Place - Hyderabad

Annexure-11

Appointment Re-Appointment
08/08/2020 01/10/2020
Upto the conclusion of the ensuing Annual Reappointed for a period of three
subject to the shareholders' approval. (3) years from O I October 2020
till 30 September 2023 subject to
the approval of shareholders at the
ensuing Annual General Meeting
Ms. C. Sirisha is an Associate Member of
the Institute of Company
Secretaries
of
India and the Institute of Cost Accountants
of India. She is a registered
Insolvency
Professional.
Further,
she
a
semi
is
qualified
Chartered
Accountant
from the
Institute of Chartered Accountants of India.
She bagged all India 7th Rank and South
India lst Rank in the Company Secretary
Final level exams.
She was associated with L&T Shipbuilding
Ltd., Chennai
- Renowned
Shipbuilding
- engaged
Company
in construction
of
Defence
Vehicles,
Interceptor
Boats,
Offshore
Patrol Vessels, Floating
Dock;
International
Seaport
Dredging
Limited,
Chennai, a joint venture dredging between
Larsen
&
Toubro
Ltd
and
Dredging
International - DEME Group, Belgium and
CCL Products
(India) Ltd, Hyderabad
-
Instant Coffee manufacturing Company as a
Company Secretary.
Mr. Ashok Atluri is the Promoter
of the company and is also the
Chairman and Managing Director
of the company since more than
two decades and has played an
instrumental role in the growth of
Zen Technologies Limited.
Ashok
Atluri,
a PG
Diploma
holder
Applied
Computer
in
Science,
instrumental
is
in
designing
the simulators
on the
Windows-Intel
platforms
to
ensure the products are simple to
use and meet industry standards.
He received
the "Small
Scale
Entrepreneur
of the Year" award
from
Hyderabad
Management
Association in 1998.
Professional Experience and Exposure:
She is having more than 11 years of good
exposure and experience
in the fields of
legal, financial, secretarial, insolvency and
other
regulatory
compliance
matters
particularly
in relation to the Companies
Act, laws applicable to the Capital Markets
and other statutes.
She has successfully
issues I
handled
and completed
various
assignments I mergers and got well-versed
with various statutes involved in the day-to
day operations of the Company.
General Meeting and further continuance

Disclosure of She is not related to any other Director(s) of Mr. Ashok Atluri is the husband
Relationships the company. of Ms. Shilpa Choudari, Whole
between directors Time Director of the company.
Declaration We
hereby
affirm
that
Ms.
Sirisha
Chintapalli is not debarred from holding the
office of Director by virtue of any SEBI
order or any other such authority.
We hereby affirm that Mr. Ashok
Atluri
not
debarred
from
is
holding the office of Director by
virtue of any SEBI order or any
other such authority.

Annexure- III

Sr No Particulars Status I Remark
I
such as size, turnover etc. Name of the target entity, details in brief I Zen Medical Technologies Private Limited
Date of Incorporation: 24/07/2020
CTN: U33119TG2020PTC142116
Authorized Capital: Rs. 10,00,000/-
Paid-up Capital: Rs. 20,000/-
Turnover Details: Nil
2 related party transaction(s)
and whether
the promoter/
promoter
group/
group
companies have any interest in the entity
being acquired? If yes, nature of interest
and details thereof and whether the same
is done at "arm's length"
I Whether the acquisition would fall within I Yes. The proposed acquisition would fall
under the related party transaction.
The existing
Promoter
Directors
of the
company i.e., Mr. Ashok Atluri and Mr.
Ravi Kumar M are also the Promoters,
first
Directors
and
Shareholders
of
ZMTPL.
The said acquisition
will be by way of
transfer
of
shares
from
the
existing
promoters of the ZMTPL at face value and
post which the company will become the
Wholly-Owned
Subsidiary (100%) of Zen
Technologies Limited.
3 I Industry
to
which
the
entity
acquired belongs
being I ZMTPL
is in the business
of research,
design,
development,
engineering,
manufacturing,
assembling,
exporting,
importing, trading, supplying, distributing,
trairung,
simulation,
servicing,
and
maintenance
of all kinds of equipment/
machinery,
systems,
components,
sub
systems
of
medical
and
hospital
equipment.
4 Objects
and
effects
of
acquisition
(including but not limited to, disclosure of
reasons for acquisition of target entity, if
its business is outside the main line of
business of the listed entity)
Due to the Novel Corona
Virus 2019
(COYID-19)
pandemic,
managing
the
requirements
of
escalating
medical
emergency
in terms of manufacturing
of
medical ventilators and the availability of
sufficient ventilators to meet the situation
is the need of the hour.
The company is already into the business
of
training
and
manufacturing
of
simulators
and is pioneer
in providing
integrated
defence
training
solutions
in
India. Further, the proposed
acquisition,
inter-alia,
will enable Zen Technologies
Limited to diversify its business plans and
also cater the need for the Medical and
by manufacturing
Hospital
requirements

the ventilators and other equipment.
ZMTPL is a potential company and will
give Zen a wide range of scope to enable
the company to tap into the medical and
hospital equipment business.
$\overline{5}$ Brief details of any governmental or
regulatory approvals required for the
acquisition
Not Applicable
6 Indicative time period for completion of
the acquisition
30 September 2020
$\overline{7}$ Nature of consideration - whether cash
consideration or share swap and details of
the same
Cash Consideration
8 Cost of acquisition or the price at which
the shares are acquired
cost of acquisition for 100%
The
shareholding is Rs. 20,000/- (Rupees
Twenty Thousand only).
9 control
Percentage of shareholding /
acquired and / or number of shares
acquired
100% shareholding
10 Brief background about the entity acquired in terms of products/line of business
acquired, date of incorporation, history of last 3 years turnover, country in which the
acquired entity has presence and any other significant information (in brief)
design, development,
engineering,
business of research,
ZMTPL is in
the
manufacturing, assembling, exporting, importing, trading, supplying,
distributing,
training, simulation, servicing, and maintenance of all kinds of equipment/ machinery,
systems, components, sub-systems of medical and hospital equipment.
ZMTPL was incorporated under the Companies Act, 2013 on 24/07/2020 with CIN
U33119TG2020PTC142116.
Further, as a newly incorporated company, the entity is yet to commence its operations
and accordingly turnover details are not available.

$\overline{\mathcal{R}}$ .